期刊
CANCER RESEARCH
卷 77, 期 2, 页码 401-411出版社
AMER ASSOC CANCER RESEARCH
DOI: 10.1158/0008-5472.CAN-16-1567
关键词
-
类别
资金
- Caring for Carcinoid Foundation [2014-565669]
- AACR-NETRF grant
- Natural Science Foundation of China [81402333]
- Shenzhen Peacock plan [KQTD20140630100746562]
- Commonwealth of PA grant [040-0427-4-561074-XXXX-2433-8341]
- [NIH/NCIR01CA178856]
- [NIH/NIDDKR01DK097555]
Neuroendocrine tumors (NET) often harbor loss-of-function mutations in the MEN1 and DAXX tumor suppressor genes. Here, we report that the products of these genes, menin and Daxx, interact directly with each other to suppress the proliferation of NET cells, to a large degree by inhibiting expression of the membrane metalloendopeptidase (MME). Menin and Daxx were required to enhance histone H3 lysine9 trimethylation (H3K9me3) at the MME promoter, as mediated partly by the histone H3 methyltransferase SUV39H1. Notably, the menin T429K mutation associated with a NET syndrome reduced Daxx binding, MME repression, and proliferation of NET cells. Conversely, inhibition of MME in NET cells repressed proliferation and tumor growth in vivo. Our findings reveal a previously unappreciated cross-talk between two crucial tumor suppressor genes thought to work by independent pathways, focusing on MME as a common target of menin/Daxx to treat NET. (C) 2016 AACR.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据